Company intelligence / Profile preview

Adona Medical

Los Gatos, California, United Statesadonamed.com ↗

Ownership: Private
Development stage: Other

Overview

Adona Medical has developed a novel, chronically-adjustable interatrial shunt with integrated bi-atrial pressure sensors for individualized management of advanced heart failure. In its first-in-human ATHENS-HF study, the device was successfully implanted in 10 patients with 100% procedural success and demonstrated effective acute hemodynamic modulation by adjusting shunt diameter post implantation. The company is preparing to advance to further clinical studies of next-generation devices later in 2025.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically, implantable interatrial shunt with integrated pressure sensors)Remote patient monitoring system
Industry: Implantable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on Adona Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adona Medical.

Explore the full profile